What is Crosspoint Engineering?
Founded in 1993, Crosspoint Engineering operates as a specialized process and controls house, delivering comprehensive engineering solutions and project management services tailored for FDA-regulated environments. The firm distinguishes itself through a rigorous commitment to quality, leveraging a deep bench of Professional Engineers and Certified Control System Technicians. Their core competency lies in bridging the gap between complex technical automation and stringent regulatory mandates, serving a diverse portfolio of clients across the pharmaceutical, biotechnology, and specialty chemical industries. By prioritizing long-term client partnerships and technical integrity, the company has established itself as a critical service provider in the industrial automation landscape.
How much funding has Crosspoint Engineering raised?
Crosspoint Engineering has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Crosspoint Engineering
PPP
Public-Private Partnership
What's next for Crosspoint Engineering?
With this recent injection of capital, Crosspoint Engineering is well-positioned to scale its service offerings and deepen its technical expertise in response to evolving industry trends. The strategic focus will likely shift toward enhancing its digital transformation capabilities and expanding its footprint within the specialty chemical sector. As the regulatory landscape for life sciences continues to tighten, the company's ability to provide robust, compliant, and efficient automation solutions will be a primary driver of its future growth. Investors and stakeholders can expect the firm to leverage this financing to optimize its project management frameworks and potentially explore new technological integrations that streamline FDA compliance for its global client base.
See full Crosspoint Engineering company page
